Snowball logo
logo
GETI_logo

Getinge AB ser. B

SEK 268.00+SEK 0.30  (0.11%)
Estimate
P/E
25.8
EPS
10.39
Beta
0.816
Growth
Revenue, YoY
2.67%
Net income, YoY
27.21%
FCF, YoY
65.57%
Forecast
P/E (FWD)
18.5
EPS (FWD)
14.481
Dividends
Dividend yield
1.77%
Annual payout
SEK 4.75
Next ex. div date
April 22, 27
Payout
46.25%
Div.growth, 5y
8.92%
Dividend growth streak
7 y
Div.rating
About the company
Ticker
GETI-B
ISIN
SE0000202624
Country
Sweden
Sector (GICS)
Healthcare
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Frequently asked questions

What sector does Getinge AB ser. B (GETI-B) operate in?

Getinge AB ser. B belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Getinge AB ser. B (GETI-B) current stock price?

As of the latest data, Getinge AB ser. B stock price is SEK 268.00, with a previous close of SEK 267.70. Getinge AB ser. B gained SEK 0.30 in the last trading session, representing a 0.11% increase.

What is Getinge AB ser. B (GETI-B) current market capitalization?

Getinge AB ser. B market cap is approximately 68.11 billion.

What is Getinge AB ser. B (GETI-B) Earnings Per Share (EPS)?

The trailing EPS is SEK 10.39, and the forward EPS is SEK 14.48.

What is Getinge AB ser. B (GETI-B) Price-to-Earnings (P/E) ratio?

Getinge AB ser. B current P/E ratio is 25.79, with a forward P/E of 18.51.

What is Getinge AB ser. B (GETI-B) EBITDA?

Getinge AB ser. B EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.70 billion.

Does Getinge AB ser. B (GETI-B) pay dividends?

Yes. Getinge AB ser. B pays annual dividends with an annualized yield of 1.77% and an estimated annual payout of SEK 4.75 per share.

When is the next ex-dividend date for Getinge AB ser. B (GETI-B)?

The next ex-dividend date is scheduled for April 22, 2027.

How did Getinge AB ser. B (GETI-B) perform in its most recent earnings report?

In the last report (September 30, 2026), Getinge AB ser. B posted an EPS surprise of 17.87% and a revenue surprise of -0.39%.

What is Getinge AB ser. B (GETI-B) beta (volatility) score?

Getinge AB ser. B has a beta of 0.816, meaning its volatility is roughly in line with the market.